Role of microRNA-155 in Brain Metastasis of Hypoxic Lung Cancer

LIU Yang, JIA Yong-sen, QIN Li-juan

Abstract

To clarify the relationship between hypoxia stress and the microRNA-155 released from lung cancer cells, to reveal the possible mechanism of brain metastases of lung cancer.  Methods  The hypoxia model of A549 lung cancer cells was established. Lung cancer cells were cultured under the hypoxia condition or normal oxygen condition as control for 0.5, 2, 4, 8, 12 and 24 h immunofluorescence and Western blot methods were used to determine the expression level of heat shock protein 70 (hsp70) in lung cancer cells. Hsp70 overexpressed lung cancer cell line was established, the levels of microRNA-155 in A549 and hsp70 overexpressed A549 cell culture medium were determined by qRT-PCR.An in vitro blood-brain barrier model was established, and was treated with A549 cell culture medium collected at different hypoxia time points. Horseradish peroxidase (HRP) was used to detect the changes of permeability of the in vitro blood-brain barrier model, automatic cell technical instrument was used to count A549 lung cancer cells in the culture medium in under Transwell room. Culture mediums of A549 lung cancer cells collected at different hypoxia time points were injected into rats via tail vein, Western blot was used to analyze the expression of occludin in brain tissue, Evans blue was used to detect the change of blood-brain barrier permeability in animals.  Results  When lung cancer cells were hypoxic cultured for 8 h, both the expression level of hsp70 in lung cancer cells and microRNA-155 in culture medium reached the highest level (P < 0.05). Compared with A549 cells, the enhancement of microRNA-155 level in culture medium of hsp70 overexpressed cell was more notably under hypoxia condition. At the same time, the permeability of blood-brain barrier was the highest, and the number of lung cancer cells crossed the blood-brain barrier model was the most. In animal experiment, after injection the lung cancer cell culture fluid with hypoxia 8 h, the tight junction protein occludin expression in blood-brain barrier was lowest, and the permeability of blood-brain barrier was the largest.  Conclusion  Hypoxia can cause the increase of hsp70 production in lung cancer cells. Increased hsp70 promotes the synthesis and release of microRNA-155, which in turn leads to reduced expression of occludin protein in the blood-brain barrier, resulting in increased permeability of the blood-brain barrier and eventually causing lung cancer cells to metastasize into the brain.

 

Keywords: Brain metastasis of lung cancer, Hsp70, microRNA-155, Tight junction protein

 

Full Text:

PDF


References


SATOH H, ISHIKAWA H, YAM ASH IT A Y T, et al. Patterns of brain metatasis in lung cancer. Oncol Rep,2001 ,8 (4);781-783.

LEE H W. LEE J I. LEE S J, et al. Patient-derived xenografts from non-small cell lung cancer brain metastases are valuable translational platforms for the development of personalized targeted therapy. Clin Cancer Res,2015,21 (5): 1172-1182.

SETIADI A.KORIM W S, ELSAAFIEN K. et al. The role of the blood-brain barrier in hypertension. Exp Physiol,2018, 103(3):337-342.

FARAONI I,ANTONETTI F R, CARDONE J, et at. miR- 155 gene: a typical multifunctional microRNA. Biochim Biophys Acta, 2009,1792(6):497-505.

PASQUINELLI A E. MicroRNAs and their targets: recognition, regulation and an emerging reciprocal relationship. Nat Rev Genet,2012,13(4) :271-282.

LOPEZ-RAMIREZ M A, WU D, PRYCE G, et al. MicroRNA-155 negatively affects blood-brain barrier function during neuroinflammation. FASEB J, 2014, 28 ( 6 ): 2551- 2565.

HOU L,CHEN J,ZHENG Y,et al. Critical role of miR-155/ FoxOl/ROS axis in the regulation of non-small cell lung carcinomas. Tumor Biol,2016 ,37(4) ;5185-5192.

СОТО A L S, SERAPHIM T V, BATISTA F A H,et al. Structural and functional studies of the Leishmania braziliensis, SGT co-chaperone indicate that it shares structural features with HIP and can interact with both Hsp90 and Hsp70 with similar affinities. Int J Biol Macromol ,2018,118; 693-706.

WILHELM I.KRIZBAI I A. In vitro models of the blood- brain barrier for the study of drug delivery to the brain. Mol Pharm,2014,11(7): 1949-1963.

HARFORD-WRIGHT E,LEWIS К M. ROBERT VINK. Towards drug discovery for brain tumours; interaction of kinins and tumours at the blood brain barrier interface. Recent Pat CNS Drug Discov,2011,6(1) :31-40.

THOMPSON E M, FRENKEL E P. NEUWELT E A. The paradoxical effect of bevacizumab in the therapy of malignant gliomas. Neurology ,2011,76( 1); 87-93.

LEMASSON B,SERDUC R.MAISIN C,et al. Monitoring blood-brain barrier status in a rat model of glioma receiving therapy: dual injection of low-molecular-weight and macromolecular MR contrast media. Radiology, 2010, 257 (2):342-352.

PANG Z, FENG L, HUA R, et al. Lactoferrin-conjugated biodegradable polymersome holding doxorubicin and tetrandrine for chemotherapy of glioma rats. Mol Pharm, 2010,7(6):1995-2005.

BLACK К L. YIN D, ONG J M. et al. PDE5 inhibitors enhance tumor permeability and efficacy of chemotherapy in a rat brain tumor model. Brain Res,2008,1230;290-302.

CONNARN J N, ASSIMON V A, REED R A, et al. The molecular chaperone Hsp70 actis'ates protein phosphatase 5 (PP5 ) by binding the tetratricopeptide repeat ( TPR ) domain. J Biol Chem,2014 ,289(5) ;2908-2917.

AHMAD O, CHAN M, SAVAGE P, et al. Biology and treatment of metastasis of sarcoma to the brain. Front Biosci (Elite Ed),2016,8:233-244.


Refbacks

  • There are currently no refbacks.